The Relationship Between Perioperative Use of Esketamine and Postpartum Depression Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

References

• Wang Z, Liu J, Shuai H, et al. Mapping global prevalence of depression among postpartum women. Transl Psychiatry. 2021;11(1):543. doi:10.1038/s41398-021-01663-6
   PubMed Web of Science ®Google Scholar
• Shorey S, Chee CYI, Ng ED, et al. Prevalence and incidence of postpartum depression among healthy mothers: a systematic review and meta-analysis. J Psychiatr Res. 2018;104:235–248. doi:10.1016/j.jpsychires.2018.08.001
   PubMed Web of Science ®Google Scholar
• Hahn-Holbrook J, Cornwell-Hinrichs T, Anaya I. Economic and health predictors of national postpartum depression prevalence: A systematic review, meta-analysis, and meta-regression of 291 studies from 56 countries. Front Psych. 2017;8:248. doi:10.3389/fpsyt.2017.00248
   PubMedGoogle Scholar
• Di Florio A, Forty L, Gordon-Smith K, et al. Perinatal episodes across the mood disorder spectrum. JAMA Psych. 2013;70(2):168–175. doi:10.1001/jamapsychiatry.2013.279
   PubMed Web of Science ®Google Scholar
• Rubin R. Postpartum Depression Persists Longer Than Previously Thought. JAMA. 2020;324(24):2475.
   Web of Science ®Google Scholar
• Slomian J, Honvo G, Emonts P, et al. Consequences of maternal postpartum depression: a systematic review of maternal and infant outcomes. Women's Health. 2019;15:1745506519844044. doi:10.1177/1745506519844044
   Web of Science ®Google Scholar
• Zhao X-H, Zhang Z-H. Risk factors for postpartum depression: an evidence-based systematic review of systematic reviews and meta-analyses. Asian J Psychiatr. 2020;53:102353. doi:10.1016/j.ajp.2020.102353
   PubMed Web of Science ®Google Scholar
• Huang XB, Zheng W. Ketamine and electroconvulsive therapy for treatment-refractory depression. Alpha Psy. 2023;24(6):244–246. doi:10.5152/alphapsychiatry.2023.231358
   PubMedGoogle Scholar
• Yuan S, Luo X, Zhang B. Individualized Repetitive Transcranial Magnetic Stimulation for Depression Based on Magnetic Resonance Imaging. Alpha Psy. 2023;24(6):273–275. doi:10.5152/alphapsychiatry.2023.231412
   PubMedGoogle Scholar
• Wen KS, Zheng W. Optimization Strategies of Transcranial Magnetic Stimulation in Major Depressive Disorder. Alpha Psy. 2023;24(6):270–272. doi:10.5152/alphapsychiatry.2023.231401
   PubMedGoogle Scholar
• Lima TM, Visacri MB, Aguiar PM. Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses. Eur J Clin Pharmacol. 2022;78(3):311–338. doi:10.1007/s00228-021-03216-8
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383–399. doi:10.1176/appi.ajp.2020.20081251
   PubMed Web of Science ®Google Scholar
• Smith-Apeldoorn SY, Veraart JK, Spijker J, et al. Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability. Lancet Psychiatry. 2022;9(11):907–921. doi:10.1016/S2215-0366(22)00317-0
   PubMed Web of Science ®Google Scholar
• Shen J, Song C, Lu X, et al. The effect of low-dose esketamine on pain and post-partum depression after cesarean section: a prospective, randomized, double-blind clinical trial. Front Psych. 2022;13:1038379. doi:10.3389/fpsyt.2022.1038379
   Google Scholar
• Wang W, Ling B, Chen Q, et al. Effect of pre-administration of esketamine intraoperatively on postpartum depression after cesarean section: a randomized, double-blinded controlled trial. Medicine. 2023;102(9):102.
   Web of Science ®Google Scholar
• Wang Y, Zhang Q, Dai X, et al. Effect of low-dose esketamine on pain control and postpartum depression after cesarean section: a retrospective cohort study. Ann Palliat Med. 2022;11(1):45–57. doi:10.21037/apm-21-3343
   PubMed Web of Science ®Google Scholar
• Wang W, Xu H, Ling B, et al. Effects of esketamine on analgesia and postpartum depression after cesarean section: a randomized, double-blinded controlled trial. Medicine. 2022;101(47)101.
   Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89. doi:10.1186/s13643-021-01626-4
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12. doi:10.1016/0197-2456(95)00134-4
   PubMedGoogle Scholar
• Higgins JPT, Green S. Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0; 2011.
   Google Scholar
• Wang W, Xu H, Ling B, et al. Effects of different doses of esketamine on analgesia and postpartum depression after cesarean section. J Cli Anesthes. 2023;39(5):501–505.
   Google Scholar
• Liu QR, Zong QK, Ding LL, et al. Effects of perioperative use of esketamine on postpartum depression risk in patients undergoing cesarean section: a randomized controlled trial. J Affect Disord. 2023;339:815–822. doi:10.1016/j.jad.2023.07.103
   PubMed Web of Science ®Google Scholar
• Guo Y, Ding X, Wang S, et al. Analgesic effect of esketamine combined with tramadol for patient-controlled intravenous analgesia after cesarean section: A randomized controlled trial. J Pain Res. 2023;16:3519–3528. doi:10.2147/JPR.S427702
   PubMedGoogle Scholar
• Han Y, Li P, Miao M, et al. S-ketamine as an adjuvant in patient-controlled intravenous analgesia for preventing postpartum depression: a randomized controlled trial. BMC Anesthesiol. 2022;22(1):49. doi:10.1186/s12871-022-01588-7
   PubMed Web of Science ®Google Scholar
• Correia-Melo FS, Leal GC, Vieira F, et al. Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: a randomized, double-blind, non-inferiority study. J Affect Disord. 2020;264:527–534. doi:10.1016/j.jad.2019.11.086
   PubMed Web of Science ®Google Scholar
• Wang J, Huang J, Yang S, et al. Pharmacokinetics and safety of esketamine in Chinese patients undergoing painless gastroscopy in comparison with ketamine: a randomized, open-label clinical study. Drug Des Devel Ther. 2019;13:4135–4144. doi:10.2147/DDDT.S224553
   PubMed Web of Science ®Google Scholar
• Zhu T, Zhao X, Sun M, et al. Opioid-reduced anesthesia based on esketamine in gynecological day surgery: a randomized double-blind controlled study. BMC Anesthesiol. 2022;22(1):354. doi:10.1186/s12871-022-01889-x
   PubMed Web of Science ®Google Scholar
• Yu L, Zhou Q, Li W, et al. Effects of esketamine combined with ultrasound-guided pectoral nerve block type ii on the quality of early postoperative recovery in patients undergoing a modified radical mastectomy for Breast Cancer: A randomized controlled trial. J Pain Res. 2022;15:3157–3169. doi:10.2147/JPR.S380354
   PubMed Web of Science ®Google Scholar
• Xu LL, Wang C, Deng CM, et al. Efficacy and safety of esketamine for supplemental analgesia during elective cesarean delivery: A randomized clinical trial. JAMA Net Open. 2023;6(4):e239321. doi:10.1001/jamanetworkopen.2023.9321
   PubMed Web of Science ®Google Scholar
• Han T, Chen Q, Huang J, et al. Low-dose esketamine with sufentanil for postcesarean analgesia in women with gestational diabetes mellitus: a prospective, randomized, double-blind study. Front Endocr. 2023;14:1202734. doi:10.3389/fendo.2023.1202734
   PubMed Web of Science ®Google Scholar
• Yang SQ, Zhou YY, Yang ST, et al. Effects of different doses of esketamine intervention on postpartum depressive symptoms in cesarean section women: a randomized, double-blind, controlled clinical study. J Affect Disord. 2023;339:333–341. doi:10.1016/j.jad.2023.07.007
   PubMed Web of Science ®Google Scholar
• Park SH, Kim JI. Predictive validity of the Edinburgh postnatal depression scale and other tools for screening depression in pregnant and postpartum women: a systematic review and meta-analysis. Arch Gynecol Obstet. 2023;307(5):1331–1345. doi:10.1007/s00404-022-06525-0
   PubMed Web of Science ®Google Scholar
• Moraes GP, Lorenzo L, Pontes GA, et al. Screening and diagnosing postpartum depression: when and how? Trends Psy Psychot. 2017;39(1):54–61. doi:10.1590/2237-6089-2016-0034
   PubMedGoogle Scholar
• Kamp J, Jonkman K, van Velzen M, et al. Pharmacokinetics of ketamine and its major metabolites norketamine, hydroxynorketamine, and dehydronorketamine: a model-based analysis. Br J Anaesth. 2020;125(5):750–761. doi:10.1016/j.bja.2020.06.067
   PubMed Web of Science ®Google Scholar
• Hashimoto K. Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective. Psychiatry Clin Neurosci. 2019;73(10):613–627. doi:10.1111/pcn.12902
   PubMed Web of Science ®Google Scholar